



EVALUATION OF ANTIDIABETIC POTENTIAL OF ROOTS AND STEMS OF G. ARBOREA 
Original Article 
 
NIYATI ACHARYAa*, PRIYAL BARAIa, HIRAL KATARIYAa, SANJEEV ACHARYAa, DEVDAS SANTANIb 
aDepartment of Pharmacognosy, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, 382481, India, b
Received: 13 Feb 2015 Revised and Accepted: 20 Jun 2015 
Department of 
Pharmacology, Rofel College of Pharmacy, Vapi, Gujarat, 396191, India 
Email: niyati20103@gmail.com   
ABSTRACT 
Objectives: Roots and stems of Gmelina arborea Roxb. (Verbenaceae) are used in many Ayurvedic (Dashmula) and herbal formulations (Diabecon) 
and reported to possess hypoglycemic activities which formed the basis of the present investigation. Methanolic extracts of stems and roots of 
Gmelina arborea were evaluated for antidiabetic activity in diabetic rats. 
Methods: Total phenolics and flavonoids were estimated in methanolic, aqueous and ethyl acetate extracts of roots and stems of G. arborea. 
Antidiabetic activity of methanolic extracts of stems and roots of G. arborea was investigated in streptozotocin induced diabetic rats for 21 days at 
two dose levels (250 and 500 mg/kg) with glibenclamide (0.25 mg/kg) used as a standard drug.  
Results: Methanolic extracts of stems and roots showed considerable amount of phenolics and flavonoids compared to aqueous and ethyl acetate 
extracts. It also showed significant (p<0.001) reduction in fasting blood glucose level in both normal and diabetic rats. Methanolic extract of stems 
and roots at 500 mg/kg showed significant decrease (54.69% and 45.31% respectively) in blood glucose levels when compared to the standard. In 
addition, change in body weight, serum lipid profile and GHb (whole blood) levels were also compared amongst various groups treated with 
different extracts and significant antidiabetic activity observed might be attributed to appreciable amount of phenolics and flavonoids in methanolic 
extract of roots and stems. The results clearly indicate potential antidiabetic effects of roots and stems of this plant. 
Conclusion: These findings support the use of G. arborea in herbal formulations for diabetes and will be helpful to explore isolation and 
identification of bioactives from this drug to manage diabetes and related complications. 
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INTRODUCTION 
Diabetes mellitus (DM) is a chronic disease caused inherited and/or 
by acquired deficiency in production of insulin by the pancreas, or 
by the ineffectiveness of the insulin produced resulting in increased 
concentrations of glucose in the blood, which in turn damage many 
of the body’s systems, in particular the blood vessels and nerves. It is 
a metabolic disorder characterized by hyperglycemia, glucosuria 
and negative nitrogen balance and it is mainly due to lack of insulin 
secretion in beta cells of pancreas and desensitization of insulin 
receptors for insulin. It causes number of micro vascular and macro 
vascular complications arisen from hyperglycemia like retinopathy, 
neuropathy and peripheral vascular insufficiencies [1, 2]. 
India leads the world with largest number of diabetic subjects 
earning the dubious distinction, “diabetes capital of the world". The 
reports of (Indian Council of Medical Research) ICMR-INDIAB 
national study indicate that 62.4 million people in India are suffering 
from type 2 diabetes and 77 million people are pre diabetics and 
these numbers are estimated to reach 101 million by 2030 [3]. 
Natural products have been playing a significant role throughout the 
world in treating and preventing human diseases. Apart from 
currently available therapeutic options, many herbal medicines have 
been recommended for the treatment of diabetes. Traditional plant 
medicines are used throughout the world for a range of diabetic 
complications. Many plants like Abelmoschus moschatus (Malvaceae), 
Acacia arabica (Leguminosae), Momordica charantia (Cucurbitaceae), 
Allium sativum (Amaryllidaceae), Allium cepa (Amaryllidaceae), 
Enicostemma littorale (Gentianaceae), Aloe vera (Liliaceae), 
Andrographis paniculata (Acanthaceae), Artemisia herba alba 
(Asteraceae), Artocarpus heterophyllus (Moraceae), Asteracanthus 
longifolia (Acanthaceae), Azadirachta indica (Meliaceae), Bacopa 
monnieri (Scrophulariaceae) and Bauhinia forficata (Fabaceae) have 
been reported for their antidiabetic activity exhibited either by the 
extracts or by isolated compounds [4]. Oxidation is essential to many 
living organisms for the production of energy to fuel biological 
processes. The role of oxygen radicals has been implicated in several 
diseases, including cancer, diabetes, cardiovascular diseases and 
aging. Oxidative stress has been considered as a cornerstone for 
pathogenesis of diabetes and its complications [5, 6]. Several studies 
revealed that medicinal plants containing appreciable amount of 
phenolics and flavonoids possess good antioxidant properties and 
exert anticarcinogenic, antimutagenic, antitumor, antibacterial, 
antiviral, antidiabetic and anti-inflammatory activities due to their 
redox properties [7], hydrogen donor and singlet oxygen quenching 
capabilities and by chelating metals [8, 9]. 
Gmelina arborea Roxb. (Family: Verbenaceae) is locally known as 
‘Gambhari’ and in English, is known as the ‘Candahar tree’ or ‘White 
teak’. It is a moderate sized, deciduous tree, found in deciduous 
forests throughout the greater part of India up to 1500 m altitude 
[10]. The roots and stems of the plant are used in many Ayurvedic 
formulations like Dashmula (stem bark) [11], Chyawanprasha (roots 
and stem bark) [12], Dasamularista, Dasamulaharitaki, Dasmula 
ghrita, Dasmula satpalaka grita (roots), Candanasava, Karpuradi 
Kuzambu (Laghu), Dantadyarista, Usirasava (stem) as well as herbal 
formulations like Diabecon & Gluco Care (hydro-alcoholic extract, 10 
mg) [13, 14] and Abana (roots) [15].  
The useful parts of the plant are its root, stem bark and fruit. 
Folklore states that it promotes digestive power, improves memory 
and is useful in fever, heart disease, nervous disorders and piles [16, 
17]. G. arborea contains number of chemical constituents like 
alkaloids, glycosides, phenylpropanoids, terpenoids, flavonoids and 
phenolics, lignans etc. Roots and heart wood of G. arborea have been 
reported to contain gmelinol, hentriacontanol, n-octacosanol and β-
sitosterol [17]. The roots have been found to contain 
sesquiterpenoids, apiosylskimmin, a coumarin characterized as 
umbelliferone-7-apiosyl glucoside and gmelofuran, an apiose-
containing coumarin glycoside [18]. The heartwood and bark of the 
plant mainly contain lignans arboreal, isoarboreol, gmelonone [19], 
gummadiol [20], 6”-bromo isoarboreol [21], paulownin [22] and 
arborone [23], flavonoids, alkaloids, sterols and various phenyl 
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propanoid glycosides [24]. Heartwood also contains ceryl alcohol 
and a new long chain ester, cluytyl ferulate [17]. The roots are acrid, 
bitter, tonic, stomachic, and laxative, galactogogue, demulcent, 
antibilious, febrifuge and anthelmintic. Bark is bitter, hypoglycemic, 
antiviral, anticephalalgic and tonic [25]. The plant extracts are 
reported for their hypoglycemic activity [26], hypolipidemic activity 
[27], diabetic nephropathy [28], anthelmintic activity [29], 
nematocidal activity [30], anti-inflammatory activity [31, 32], 
antioxidant activity [33], antimicrobial [34], antiulcer activity [35], 
wound healing activity [36], antidiarrheal activity [37] and 
immunomodulatory activity [38]. Keeping in view the reports 
suggesting multifaceted uses of this drug in various formulations, 
present study was undertaken to evaluate and compare stems and 
roots of this plant in order to evaluate antidiabetic potential of stems 
and roots.  
MATERIALS AND METHODS 
Chemicals 
All chemicals and reagents used were of analytical grade. All the 
solvents were procured from CDH chemicals, New Delhi (India) and 
enzymatic kits (total 5) were acquired from Lab Care Diagnostics 
Pvt. Ltd., Mumbai (India). Streptozotocin and glibenclamide were 
acquired from Sisco Research Laboratory, Mumbai (India) and 
Aventis Pharma Ltd., Mumbai (India) respectively.  
Plant material 
Fresh roots and stems were collected from fully-grown trees from 
fields from the outskirts of Ankleshwar city near Dist. Bharuch, in 
October 2010. Root and stem pieces were dried under the shade and 
powdered (passed through 40#). The powder was stored in air tight 
container and used for the further study. The authenticity was 
established by comparing its morphological and microscopical 
characteristics [39, 40] and by an ethanobotanist, Dr. Bhasker L. 
Punjani, of Smt. S. M. Panchal Science College, Talod (Dist. 
Sabarkantha). Voucher specimen, PL11NSAHKga001 was preserved 
at Department of Pharmacognosy, Institute of Pharmacy, Nirma 
University, Ahmedabad. Total phenolic and flavonoid content of 
roots and stems of G. arborea was determined in methanolic (ME), 
ethyl acetate (EAE) and aqueous extracts (AE) by subjecting root 
and stem powder to extraction with methanol, ethyl acetate and 
water respectively. 
Estimation of phenolic substances [41] 
One g of air-dried powder of roots and stems of G. arborea was 
extracted with 100 ml of methanol, water and ethyl acetate by 
maceration for 24 h to prepare different extracts and then filtered. 
The final volume of each filtrate was adjusted to 100 ml. Five ml of 
these extracts was diluted with an equal volume of methanol and 
was used for the estimation of phenolics.  
To 10 ml of each extract, 10 ml of distilled water and 1.5 ml of 
diluted (1:2) Folin Ciocaulteau reagent was added and the mixture 
was kept for 5 min. After adding 4 ml of 20% Na2CO3
Estimation of flavonoids [42]  
 solution, the 
final volume was adjusted to 25 ml using distilled water. The 
absorbance was measured at 765 nm at an interval of 30 min up to 2 
h and distilled water was used as a blank. The data was compared 
with similarly prepared set of standard substance-Gallic acid, in 
concentration range of 50 µg to 300 µg per 25 ml. Total phenolic 
content was calculated by the method described [41]. 
One g of air-dried powder of roots and stems of G. arborea was 
extracted with 100 ml methanol, water and ethyl acetate by 
maceration for 24 h and filtered. The final volume of each filtrate 
was adjusted to 100 ml. One ml of these extracts was diluted up to 
10 ml with methanol and was used for the estimation of flavonoids. 
To 3 ml of the each extract, 3 ml of methanolic AlCl3
Extraction 
 was added. 
After 10 min, the absorbance was read at 430 nm and distilled water 
was used as a blank. The data was compared with similarly prepared 
set of standard substance quercetin in concentration range of 25 µg 
to 300 µg per 25 ml. Total flavonoid content was calculated by the 
method described [42].  
Methanolic extracts of stems and roots showed appreciable amount 
of phenolics and flavonoids, hence methanolic extract was selected 
further for the evaluation of antidiabetic potential. 100 g of powder 
of roots and stems was subjected separately to continuous and 
sequential hot solvent extraction using 500 ml 50% methanol in a 
soxhlet apparatus for 48 h.  
Filtrates were evaporated near to dryness and then dried at 40 °C in 
hot air oven and stored in air tight container for further use. 
Suspension of methanolic extract of roots (MER) and stems (MES) of 
G. arborea were prepared using 0.5% carboxymethyl cellulose 
(CMC) in normal saline because MER and MES were not fully 
insoluble in distilled water. 
Pharmacological activity 
Animals 
Healthy adult Wistar rats of either sex weighing between 250-300 g 
were selected for the study. Animals were maintained at 25±2 °C 
and kept in a well-ventilated animal house under natural 
photoperiodic condition in polypropylene cages with free access to 
food and water. During the period of experiment, the animals were 
fed with the standard rat diet. They were kept for 1 week in 
laboratories before the experiments for acclimatization to the 
laboratory conditions. Prior to experimental treatments, animals 
were fasted overnight but were allowed free access to water. Six 
animals were used for each group of study.  
All experiments and protocols described in present study were 
approved by the Institutional Animal Ethics Committee (IAEC) of 
Institute Of Pharmacy, Nirma University, Ahmedabad and with 
permission from Committee for the Purpose of Control and 
Supervision of Experiments on Animals (CPCSEA), Ministry of Social 
Justice and Empowerment, Government of India. Protocol number 
for the present study was given IPS/PCOG/MPH1011/2016 and 
item number given was 16. MER and MES of G. arborea were given 
orally in doses of 250 and 500 mg/kg and glibenclamide (0.25 
mg/kg) were given orally while STZ was given intravenously into 
tail vein (45 mg/kg) after dissolving in citrate buffer (1 mol, pH 4.5). 
Sample collection and estimation of blood glucose level 
Blood samples were collected by retro-orbital plexus puncture 
method using glass capillary without any anticoagulant, then each of 
the blood sample was centrifuged at 10 000 rpm for 30 min at 5 °C 
and the serum was separated and kept at 5 °C until further use. 
Blood glucose (mg/dl) was measured using Glucose SLR enzymatic 
kit (Lab Care Diagnostics, Mumbai (India) Pvt. Ltd) [43]. 
Effect of MER and MES of G. arborea on normal rats 
(Normoglycemic activity) and oral glucose tolerance test 
(OGTT) on glucose loaded rats 
Rats were divided randomly into six different groups (n=6) each for 
normoglycemic and OGTT study and received the treatment like 
Control group: 0.5% CMC, (1 ml/kg), Standard group: glibenclamide 
(0.25 mg/kg), R250:methanolic extract of roots (250 mg/kg), 
R500:methanolic extract of roots (500 mg/kg), S250:methanolic 
extract of stems (250 mg/kg), S500:methanolic extract of stems 
(500 mg/kg).  
All samples were given orally using oral gastric gavages and blood 
samples from each group were collected after oral administration at 
0, 1, 2, 3, 5 and 24 h and total blood glucose level was estimated [43]. 
In OGTT model, all groups were administered glucose solution (2 
g/kg, p. o.) along with the respective doses of the treatment to 
induce glucose loading and fasting blood sugar level of each rat was 
determined at zero time, after overnight fasting with free access to 
water. Glucose solution was administered 30 min after the 
administration of MER and MES. Blood samples were collected 
before (0 min) and after oral administration of vehicle, standard, 
MER (250 and 500 mg/kg) and MES (250 and 500 mg/kg) at 30, 60, 
120, 150 and 180 min and total blood glucose levels of each animal 
was estimated in glucose loaded rats [43, 44]. 
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Evaluation of antidiabetic activity of MER and MES of G. arborea 
on streptozotocin (STZ) induced diabetic rats  
Induction of diabetes 
Diabetes was induced in rats by the intravenous (i. v.) injection STZ 
in tail vein at a dose of 45 mg/kg body weight dissolved in citrate 
buffer (1 M, pH 4.5) (1 ml/kg). Animals were allowed to fast 
overnight prior to STZ injection. To avoid the hypoglycemia during 
the first day after the STZ administration, all the diabetic rats were 
given 5% glucose solution orally. Three days after the injection, 
blood glucose levels were measured and the animals with blood 
glucose levels above 250 mg/dl were confirmed as diabetic ratsand 
used for further study [43]. 
Evaluation of antidiabetic activity 
The diabetic rats were randomly divided into seven different groups 
with six rats in each group with dosage regimen, control: 0.5% CMC, 
(1 ml/kg), diabetic control: STZ, 45 mg/kg, i. v., glibenclamide as 
standard (0.25 mg/kg), R250:methanolic extract of roots (250 
mg/kg), R500:methanolic extract of roots (500 mg/kg), 
S250:methanolic extract of stems (250 mg/kg), S500:methanolic 
extract of stems (500 mg/kg). Standard as well as extracts were 
administered orally and all groups except the control group received 
STZ (45 mg/kg, i. v.) along with respective doses of treatment. 
All test samples and standard drug were administered orally using 
oral gastric gavages tube for 21 days consecutively. Blood glucose 
levels were determined at day 1, 7, 14 and 21 of the study. Finally on 
day 21, blood samples were collected from all the groups and 
evaluated for various parameters in blood and serum and the blood 
samples were collected on 30th
Biochemical estimations 
 day for estimation of insulin [44-46]. 
The serum levels of Glucose [47], Creatinine [48], Total Protein (TP) 
[49], Triglyceride (TG) [50], Total Cholesterol (TC) [51], Insulin and 
High Density Lipoprotein cholesterol (HDLC) [52] were determined 
spectrophotometrically using enzymatic colorimetric assay kits (Lab 
Care Diagnostics Pvt. Ltd., Mumbai, India). While Low Density 
Lipoprotein Cholesterol (LDLC), Very Low Density Lipoprotein 
Cholesterol (VLDLC) and Antiartherogenic Index (AAI) were 
calculated using Friedewald’s equations [53, 54]. The blood level of 
glycosylated hemoglobin (GHb) [54] was determined spectro 
photometrically by enzymatic colorimetric assay kits (Lab Care 
Diagnostics Pvt. Ltd., Mumbai, India). 
Statistical analysis 
All the values are expressed as mean±S. E. M. and statistics was applied 
using Graph pad prism 5. Two way ANOVA followed by Bonferroni was 
used to determine the statistical significance between different groups in 
determination of blood sugar levels and one way ANOVA followed by 
Dunnett’s was used for the determination of significance between 
various groups for biochemical parameters. 
RESULTS  
Estimation of total phenolic and total flavonoids content 
On determination of total phenolic and flavonoid content in 
methanolic extract (ME), aqueous extract (AE) and ethyl acetate 
extract (EAE) of roots and stems, it was observed that the 
methanolic extract of roots (MER) contained highest amount of 
phenolics (0.925 %) while flavonoid content (0.8%) was found 
higher in AE. In case stems, methanolic extract (MES) showed 
highest amount of phenolics (0.634%) and flavonoid content (0.9%) 
(fig. 1 and 2). On the basis of considerable amount of phenolics and 
flavonoids in methanolic extracts, MER and MES were selected 
further for evaluation of antidiabetic activity (fig. 3 and 4).  
Effect in normoglycemic rats (NG) and Oral glucose tolerance 
test in rats (OGTT) 
Administration of MER and MES of G. arborea showed decrease in 
blood glucose level after 60 min in all groups of animals (fig. 5). The 
group treated with glibenclamide showed significant (p<0.01) 
reduction in blood glucose levels at the beginning and at 30 min 
(p<0.001) and 180 min (p<0.01) after glucose administration 




Fig. 1: It shows standard curve for total phenolic content 
estimation (Gallic acid) 
 
 




Fig. 3: It shows total flavonoid and phenolic content of roots of 
G. arborea (n=3) 
 
 
Fig. 4: It shows total flavonoid and phenolic content of stems of 
G. arborea (n=3) 
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We observed that group treated with S500 showed significant 
decrease (P<0.001) (85 mg/dl) in blood glucose levels compared to 
the control group at 180 min. Results of the study in normoglycemic 
indicated that MER and MES showed slight increase in blood glucose 
level, followed by the decrease in blood glucose level after 3 h (fig. 
6). The group treated with glibenclamide showed significant 
reduction in blood glucose levels at 3 h (p<0.001), 5 h (p<0.01) and 
24 h (p<0.001) after treatment as compared to control group, while 
decrease in blood glucose levels in test groups were found within 
the normal range. 
 
 
Fig. 5: It shows effect of different concentrations of MER and MES of G. arborea on oral glucose tolerance test (OGTT) 
Values are expressed as mean±SD from 6 rats in each group, asignificantly different from control group p<0.01 and b
 
significantly different 
from control group P<0.001 
 
Fig. 6: It shows effect of different concentrations of methanolic extracts of powdered roots and stems of G. arborea on normoglycemic 
animals, Values are expressed as mean±SD from 6 rats in each group, asignificantly different from control group p<0.01 and b
 
significantly 
different from control group p<0.001 
 
Fig. 7: It shows effect of different concentrations of methanolic extracts of powdered roots and stem of G. arborea on total blood glucose 
level in STZ induced diabetic rats, Values are expressed as mean±SD from 6 rats in each group, asignificantly different from control group, 
p<0.001;bsignificantly different from disease control and control group, (p<0.001); csignificantly different from disease control (p<0.001) 
and control group (p<0.01); dsignificantly different from disease control group (p<0.001) 
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Evaluation of antidiabetic activity of MER and MES of G. arborea 
on streptozotocin (STZ) induced diabetic rats 
In order to determine chronic effect, MES and MER were 
administered at two dose levels (250 and 500 mg/kg) to the rats 
for 21 days and blood glucose levels were monitored changes in 
blood glucose levels were followed by 7 days in all groups (fig. 
7). S500 showed highest % decrease in blood glucose level 
(54.69%) compared to R250, R500 and S250 which showed 
marked decrease in the order, R500 (45.31%)>S250 
(41.05%)>R250 (40.57%) compared to standard (52.01%). Body 
weights of animals were found to decrease significantly 
(p<0.001) in diabetic control group as compared to control from 
day 7 (fig. 8). Our results suggested that R250 and S250 were 
able to show restoration of body weights near to normal 
significantly (p<0.001) after 21 days. 
 
Fig. 8: It shows effect of different concentrations of methanolic extracts of powdered roots and stem of G. arborea on body weight of STZ induced 
diabetic rats, Values are expressed as mean±SD from 6 rats in each group, asignificantly different from control group, P<0.0001;bsignificantly 
different from disease control and control group, (p<0.001); csignificantly different from disease control (p<0.001) and control group 
(p<0.01); dsignificantly different from disease control group (p<0.001); e
 
significantly different from control group, (p<0.01) 
Table 1: It shows effect of MER and MES (250 and 500 mg/kg) of G. arborea on serum profile and whole blood (GHb) in STZ induced 
diabetic rats 
Group TG TC HDLC LDLC VLDLC AAI TP Creatinine GHb 
(mg/dl) (mg/dl) (mg/dl) (mg/dl) (mg/dl) (%) (g/dl) (mg/dl) (%) 






































































































































TG: Triglyceride; TC: Total cholesterol; HDLC: High density lipoprotein cholesterol; LDLC: Low density lipoprotein cholesterol; VLDLC: Very low 
density lipoprotein cholesterol; AAI: Antiatherogenic Index, TP: Total protein; GHb: Glycosylated Hemoglobin, Values are expressed as mean±SD 
from 6 rats in each group. asignificantly different from control group at p<0.001, bsignificantly different from diabetic control group at P<0. 001 
and c
 
significantly different from standard group (glibenclamide treated) at p<0.001(ANOVA followed by Dunnett) 
 
Fig. 9: It shows effect of methanolic extracts of powdered roots and stems of G. arborea on insulin in streptozotocin induced diabetic rats 
Values are expressed as mean±SD from 6 rats in each group. asignificantly different from control group p<0.01 and bsignificantly different 
from diabetic control group P<0.05 (ANOVA followed by Dunnett) 
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Biochemical estimations 
Effects of MER and MES (250 and 500 mg/kg) of powdered G. 
arborea on serum profile is summarized in table 1. Significant 
increase in the levels of TG, TC, LDLC, VLDLC, creatinine and GHb 
while decrease in levels of HDLC, AAI and TP was observed in the 
diabetic group compared to the normal control group (table 1). All 
the extracts as well as standard showed significant decrease 
(p<0.001) in TG, TC and LDLC and showed increased levels of HDLC 
and AAI comparable to standard. The animals treated with 
glibenclamide showed highest decrease in TC levels amongst all, 
while animals in group S500 showed highest decrease in TG 
(60.04±0.473 mg/dl) from all test groups. Group treated with R500 
showed most significant decrease (p<0.001) in TC (70.63±0.1984 
mg/dl) and LDLC (19.52±1.390 mg/dl) as well as most significant 
increase in HDLC (36.47±1.089 mg/dl) levels and AAI 
(106.56±16.36 %) amongst all groups compared to the diabetic 
control and standard. Standard as well as Group S500 showed 
highest decrease in glycosylated hemoglobin (3.969±0.202 %), 
significant decrease (p<0.001) in serum creatinine and insulin 
(22.52±2.941 μU/ml) levels. Results of all the biochemical 
parameters indicated that R 500 was highly active in restoring the 
levels of TC, HDLC, LDLC and AAI whereas S500 was highly active in 
restoring the levels of TG, TP, creatinine, GHb and Insulin. 
DISCUSSION 
Stems and roots G. arborea have been explored for its chemical 
profile but exhaustive literature review of this plant revealed that 
systemic and scientific reports for its antidiabetic potential are very 
limited. Preliminary phytochemical screening of stems and roots 
revealed highest amounts of phenolics (0.925 %) and flavonoids 
(0.634 %) respectively in MER and MES of G. arborea and they 
possess a wide range of therapeutic uses. Within that context, 
antidiabetic activity of MER and MES of G. arborea was investigated 
in streptozotocin induced diabetic rats which is a widely used model 
for assessment of antidiabetic activity [43]. Both extracts showed 
hypoglycemic activity in glucose loaded animals (OGTT) and MES 
(500 mg/kg) showed good hypoglycemic action after 60 min, 
comparable with the standard. Up on administration of STZ to the 
normal rats, experimental diabetes was observed with severe 
hyperglycemia and decreased body weight due to increased muscle 
wasting and loss of tissue proteins [58]. This model is mimicking 
type 1 diabetes mellitus and hence there is destruction of the β cells 
of islets of Langerhans in the pancreas, and thus the normal blood 
sugar levels were not achieved by most of the extracts in our study. 
Only MES (500 mg/kg) showed 54.69 % decrease in blood glucose 
level which was comparable with reference standard, glibenclamide 
(52.01 %). While MER (500 mg/kg), MES (250 mg/kg) and MER 
(250 mg/kg) showed significant decrease in blood glucose level, 
45.31 % (p<0.001), 41.05 % (p<0.001) and 40.57 % (p<0.001) 
respectively. Results of antidiabetic experiment revealed that MES 
(500 mg/kg) possessed most significant (p<0.001) hypoglycemic 
activity. Further, animals treated with MER and MES at 500 mg/kg 
and standard showed remarkable protection against loss of body 
weight as compared to diabetic control animals.  
In diabetic condition, there is an elevation in total cholesterol, 
triglyceride, phospholipids, protein composition, creatinine level 
and glycosylated hemoglobin levels [54]. After 21 days treatment 
with MER, MES and glibenclamide, depletion observed in levels of 
triglyceride, total cholesterol, LDL cholesterol, VLDL cholesterol, 
antiatherogenic index and glycosylated hemoglobin. HDL 
cholesterol, total protein and creatinine level were found increased 
as compared to diabetic control group suggesting that protective 
effect of MER and MES might be through affecting the cholesterol 
synthesis [59]. 
Group MER (500 mg/kg) showed highest decrease in TC and LDLC 
and highest increase in HDLC level as well as AAI, while MES (500 
mg/kg) also reduced TG, TC, LDLC and VLDLC levels whereas 
increased HDLC levels. This result indicates that both roots and 
stems have potential to maintain normal levels of cholesterol and 
triglycerides in diabetic condition. Diabetes mellitus often involves 
abnormal lipid metabolism and hyperglycemia produces marked 
increase in serum triglycerides and total cholesterol. This 
hyperlipidemia associated with diabetes mellitus may be attributed 
to insulin deficiency. Under normal circumstances, insulin activates 
lipoprotein lipase which hydrolyzes triglycerides. Insulin deficiency 
results in failure to activate the enzymes, thereby causing 
hypertriglyceridemia [36, 60]. Normalization of the blood glucose 
resulted in significant reductions in serum cholesterol and 
triglycerides protein. In the present study, MER and MES (500 
mg/kg) resulted in normalization of serum lipids as standard, which 
might have contributed to the beneficial effect on pancreatic β cells. 
Glycosylated hemoglobin is a marker of glycemic control and in 
uncontrolled or poorly controlled diabetic condition increased 
glycosylation of number of proteins has been reported [61]. Our 
results suggest that MER and MES at all tested levels were able to 
significantly (p<0.001) lower GHb and the results were quite 
comparable with the standard. Further, marked decrease in TP in 
diabetic control groups was restored near to normal in groups 
treated with MER and MES but not in the standard group.  
The effects of streptozotocin on glucose and insulin homeostasis 
reflects the abnormalities in β-cell functioning [62, 63]. In our study, 
the insulin was found significantly (P<0.05) elevated compared to 
greatly depleted levels in diabetic control (13.03±1.136 µU/ml) with 
the highest levels observed in S500 (22.52±2.941 µU/ml) followed 
by R500 (22.14±2.848 µU/ml) and S250 (22.06±2.133 µU/ml). The 
decreased serum glucose as well as increased serum and pancreatic 
insulin observed in our study indicated that amongst all test groups, 
MER and MES have presented promising antidiabetic action. 
CONCLUSION 
The present research suggests a strong platform for further studies 
of mechanism behind the observed anti diabetic activity of MER and 
MES. Flavonoids and phenolics rich composition of stems and roots 
might be responsible along with the other constituents for 
promising anti diabetic activity. MER and MES (500 mg/kg) may be 
further subjected to investigation and bioactivity guided separation 
of markers from the plant. 
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